We are proud to announce that HealthSource is part of a North American observational study (CUSIOS Trials) looking at how integrative medical care impacts patients with advanced cancer. Read more about the study here:
HealthSource Integrative Medical Centre is proud to share that we are a part of a North America-wide observational study to explore the impact of advanced integrative care delivered by Naturopathic Doctors for patients with advanced cancer.
Integrative oncology aims to combine the best of conventional and whole-person naturopathic care seamlessly and safely to: improve survival, enhance quality of life, reduce side effects from conventional treatments and help prevent recurrence. The goals of the Canadian/US Integrative Oncology Study (CUSIOS) are to observe and measure the overall survival of late stage cancer patients who receive advanced integrative oncology treatments, and to describe integrative therapies provided by naturopathic doctors.
A total of 400 people with advanced breast, colorectal, pancreatic, and ovarian cancer will be studied in ten clinics across North America over three years. Each participating advanced integrative oncology clinic provides comprehensive whole-person care in naturopathic oncology, applying advanced science-based treatment for people with late-stage cancer.
CUSIOS study objectives
Bastyr University (BU) and the Canadian College of Naturopathic Medicine (CCNM) are dedicated to supporting cancer research and studying overall outcomes in patients receiving Advanced Integrative Oncology (AIO) care. We want to investigate the impact of AIO care in advanced stage cancer patients, specifically stage 4 breast and colorectal cancer and stage 3 and 4 ovarian and pancreatic cancer. Therefore, we are conducting an observational study where we collect data on patients receiving AIO care at one of the participating AIO clinics in Canada and the United States (US).
What is Advanced Integrative Oncology (AIO) care?
AIO care is defined as comprehensive support for each stage of a cancer patient’s standard oncology experience (from diagnosis and treatment decisions to restoration of immune function and health after completion of standard treatments). Patients included in this study receive care from licensed naturopathic physicians who have AIO training.
Treatment options may include dietary supplements, mind/body medicine, botanical medicine, hydrotherapy, hyperthermia, nutritional support, acupuncture, and advanced intravenous therapies. Naturopathic doctors providing AIO care communicate with each participant’s medical and radiation oncologists to ensure truly integrated care. The goal is to improve not just the quality of life for people living with cancer, but also to improve overall survival. AIO care is conducted according to community standards of care and is individualized and typically paid for by the patients themselves or by patients’ medical insurance.
Study Specific: Cancer Types
The CUSIOS will focus on the following cancer types and specific stages:
Stage 4 breast cancer
Females with primary breast cancer; and Metastatic breast cancer in one or more distant site (s) including bones, liver, lungs, brain or any other site in the body outside of breast or regional lymph nodes.
Stage 4 colorectal cancer
Primary colon or rectal cancer; and Metastatic colorectal cancer in one or more distant site(s) including liver, lungs, bone, brain or any other site in the body outside of the colon or rectum.
Stage 3 or 4 ovarian cancer
Primary ovarian cancer; and Metastatic ovarian cancer in one or more distant site(s) including peritoneum, uterus, diaphragm, liver, lungs, bone, brain or any other site in the body outside of the ovary.
Stage 3 or 4 pancreatic cancer
Primary pancreatic cancer; and Metastatic pancreatic cancer in one or more distant site(s) including liver, lung, diaphragm, bone, brain or any other site in the body outside of the pancreas.
How does someone become part of the study?
Dr Reid at HealthSource Integrative Medical Centre will screen each and every oncology patient to determine whether or not they are eligible candidates for the study. This occurs during the initial assessment as a new patient. If a patient both meets the eligibility criteria and accepts the opportunity to participate, they will be guided through an informed consent process and entered into the study.
What does it mean for the patient?
The design of this study is observational, meaning that the treatments and care a patient receives is no different whether a patient is in the study or not. The results are reviewed in retrospect, after they have occurred, and are not changed or modified during the course of the study. The study is focused on the collection of information only, in order to advance the field of advanced integrative oncology.